A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions: Infection; Rheumatoid Arthritis Interventions: Drug: Tocilizumab; Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors: Sungkyunkwan University; Ministry of Food and Drug Safety, Korea Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Arthritis | Enbrel | Humira | Remicade | Research | Rheumatoid Arthritis | Rheumatology | Study